Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies

Smitha Uthaman; Deborah Lu; Thomas Kowalski

doi:10.5912/jcb499

Authors

Smitha Uthaman Vedder Price P.C.
Deborah Lu Vedder Price P.C.
Thomas Kowalski Vedder Price P.C.

DOI:

https://doi.org/10.5912/jcb499

Keywords:

America Invents Act, Post-grant review, law, patent

Abstract

This paper summarizes the Post-Grant Review process, one of the many interesting aspects of patent reform brought about by the enactment of the America Invents Act, and the effect it may have on how Biotechnology companies conduct business and manage their intellectual property.

Author Biographies

Smitha Uthaman, Vedder Price P.C.

Intellectual Property Group, Scientific Advisor/Patent Agent (LR)

Deborah Lu, Vedder Price P.C.

Intellectual Property Group, Shareholder

Thomas Kowalski, Vedder Price P.C.